News - May 22, 2019
You still have a bit more than one month to contribute to the EMA’s next strategy for regulatory science! The European Medicines Agency (EMA) is indeed seeking views from stakeholders, partners and the general public on its proposed strategy on… read more
News - May 7, 2019
On 17 June 2019, the EU Commission (EC) will gather a large spectrum of stakeholders from the Member States, patients, academia, healthcare professionals and industry to collect their views on the successes and limitations of the regulatory framework for Paediatric… read more
News - April 26, 2019
Our member MAP BioPharma recently put forward a series of recommendations focused on UK’s appraisals and reimbursement processes, in their latest publication titled Access to Orphan Medicines: A Case for Change. The report shows that: Very small differences between treatments in… read more
News - April 16, 2019
France Biotech, with the help of the European health innovation ecosystem, is organising a HealthTech Investor Day in Paris on 24/25 June 2019. This European business event aims to connect leading investors (European, American and Asian), pharmaceuticals companies and C-level… read more
News - April 1, 2019
In the event the United Kingdom leaves the EU without a deal, access to medicines may be affected and to alleviate any doubts, the EMA has published a questions & answers document on the preparatory work to prevent medicine shortages…. read more
